Shares of Sorrento Therapeutics (NASDAQ:SRNE) fell on Wednesday after the biopharmaceutical company fired its chief financial officer. By the close of trading, Sorrento's stock was down 9.9%.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,